Peer Review History
| Original SubmissionMarch 28, 2025 |
|---|
|
Dear Dr. Dsani, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Reviewer 1 The study uses a quantitative approach based on a thematic analysis of surveillance actors’ discourse to explore the challenges of operationalizing the One Health concept for the surveillance of zoonotic diseases, through the lens of collaboration across actors, at the sub-national level. Based on the findings of this analysis, the authors claim that they provide insights to strengthen intersectoral collaboration and improve public health outcomes. The manuscript is well written and easy to read up to the end of the methods section. Conversely, the format of the results section should be deeply revised. The thematic analysis allows you to identify relevant themes related to your research questions. But, when describing the results, and especially in a scientific article, you need to bring back everything together in a well-articulated text. No need to clearly state Theme 1, sub-theme 1, etc. They are not themes anymore, they are what you are willing to describe, eg factors. You can have one separate part for each key factors and then describe the sub-themes in these parts, mentioning if they are acting as barrier or driver. Then for parts B, C, and D, you should write a descriptive analysis of your factors and not provide the results in a table. You can refer to other articles in that field to see how to better structure your result section. I think this should allow you to group some of the sub-themes together among themes and across themes, among parts and across parts (see my comment in the Results sections about merging the 4 parts as motivation, expectations and benefits can also be considered as factors influencing collaboration). Some seem redundant. In addition, it is difficult to see how some verbatims are illustrating the text (for instance, verbatim lines 309-313). There are a lot of redundancies and inconsistencies in the discussion part. I suggest to restructure this part and make your message clearer. There are very interesting and innovative ideas but they are drowned out by repetition of things already said elsewhere in the discussion section or even in the results section. I have provided one example in the comment below, but it applies to other parts of the discussion. I am also surprised that you address the need to align expectations among stakeholders from the different sectors on one hand, but refer to collaboration outcomes only for public health on the other (lines 29-30). One Health is seeking shared benefits across the human, animal and ecosystem health. Supporting this anthropocentric definition of One Health – as done in this manuscript- is contributing to maintain expectation gaps across sectors. In general, you need to write more and avoid making lists with bullets or tables with a lot of text that is difficult to read You use “cross-sectoral”, “cross sector” and “inter-sectoral” to characterize collaboration in your manuscript. If you use them interchangeably, I would suggest to opt for one and keep it all along the manuscript. If they have different meaning, please specify. I would suggest to keep intersectoral collaboration in full, instead of using an acronym. Some typos need to be corrected. Abstract Line 28 : I would not use district as a synonym of operational – so better to choose between district and operational, and not keep the two side-by-side Line 35: when you say “governance and surveillance organization”, is organization applied to surveillance and governance or to surveillance only? In both cases, it sounds a bit strange to me. I wonder if “surveillance governance and organization” would not be more suitable. You announce 9 factors but I count only 8. Line 39: Please specify the outcomes of what. Collaboration? Line 45: we usually prefer to use collaboration without s Introduction Line 57: I do not see how limited public health infrastructure can favor spillover. Can you clarify? Line 59: 28 934 is not really an approximation and I am a bit skeptical about our capacity to count cases so precisely, especially in SSA where surveillance systems are weak … I would suggest “approximately 30 000”. Line 62: I think you could improve you definition of One Health. It is an integrated approach but it does not integrate healths – it recognizes that they are interconnected, which require “integrated” actions. Lines 63-65: I do not understand this sentence. Please clarify. Line 67: I would suggest to change “district (operational)” for “sub-national”. And then specify that you are working at the level of the district (and why) in the methodology part. Line 75 : I would suggest to delete “, or fails” that suggest that you anticipate that it is not working Line 79. I suggest to add “for zoonotic diseases” after systems. Methods Lines 101-102. Please describe briefly these criteria for the reader, so he.she can assess the potential impacts on the study results Line 119: the number of invitations sent is missing – did everyone accept to be part of the interview? if not, why? We are also missing the distribution of participants across the 16 districts to assess the level of representativity of each district Lines 137-138: ECoSur details organizational (at governance and operational level) and functional attributes (and not functional and governance attributes) Line 138. The “.” should be replaced by a “;”. Line 154 : I do not get how multiple readings ensure accuracy ; and accuracy of what? please explain I suggest to put together paragraph lines 80-82 with paragraph lines 91-96, and move the contents of lines 83-90 to the method part. It is usually advised that the coding is done by two people to improve accuracy. If you did not do it, you need to discuss this potential bias in the limits of the method Lines 171-178: the contents of these 2 paragraphs should be moved to Study design and Data collection Results Why did you address motivation, expectations, and perceived benefits separately from factors driving and hindering collaboration? To me they are also factors that influence collaboration. And you present them as such at the beginning of the discussion (lines 621-622). Please clarify and explain how everything is linked, or introduce them as specific themes in part A. and merge everything together Lines 183: why perceived? they were suggested by participants as factors? It is not what I understood in the methodology. They are perceptions of interviewees that you have identified, with your coding process, as being determinants to collaboration; but to me, they are not perceived factors per se (which suggests that interviewees identified themselves the factors) Line 186. I do not think that an expectation can be perceived Line 189: I do not get why assigning a unique identifier to participant will allow to link quotes to specific individuals. And I think the reader needs this information to assess the diversity of individuals you are quoting. It would be even better if you could give a code to the district where the interviewee is working to assess the representativeness of the districts Lines 196-197: you said that the factors are grouped into 2 categories (structural and individual) but then these categories are not used in the description of the factors. In addition, in the abstract you mention sociocultural, structural and governance factors, but you do not identify these groups in the Result section. You need to harmonize across the text. Then in the discussion part, you mention again the structural and individual factors but we do not know which ones fall into these 2 categories. Discussion In the abstract, you mention that levers for better collaborations are stronger governance, equitable partnerships, and realistic alignment of stakeholder expectations. However, in the discussion, we do not identify these 3 main levers. Lines 633-634. Please explain and not only make references to other articles. Lines 655-657. You refer to participants discourse but you had references to other studies. This is inconsistent. Lines 658-659. I do not see the link between the profit-driven dimension of collaboration and resource disparities among stakeholders. Please specify. Lines 678-683. I do not see how ideas in this paragraph articulates with each other. How will mutual respect and engagement contribute to raise awareness and access? It is also partly redundant with the contents of the paragraph before. Lines 684-690 seem redundant with what has been said before (sectoral visibility) Lines 754. You mention that focusing on Ghana prevents the generalization to other LMICs but in the abstract you state that you results are applicable to other LMICs. Please be clearer on what can be generalized and what cannot. In addition, you have worked on a limited number of districts in a single region. Can you even generalize your results to Ghana? Please discuss this point. Conclusions Lines 771. This is not the first study highlighting the role of informal networks, personal initiative, and structural Constraints in intersectoral collaboration. This has been described in some of the literature cited in this study; Line 779. Inconsistent with the limit you have mentioned above, about the generalization of your work (see my comment above). Line 780. Only public health outcomes? how about animal health outcomes? Economic outcomes? Social outcomes? … Reviewer 2 In this submission to PLOS One, the authors explore the factors influencing collaboration in zoonotic disease surveillance and response at the district (operational) level, providing insights to strengthen cross-sector collaboration and improve public health outcomes. The authors use reflexive thematic analysis to analyze interviews with 66 professionals from the human, animal, and wildlife health sectors, all directly involved in zoonotic disease surveillance and response. The authors find that their study provides insights into these realities, highlighting the need for stronger governance, equitable partnerships, and realistic alignment of stakeholder expectations. I consider this manuscript to be of interest to machine learning researchers in biological systems as well as readers of this journal. As such, I am generally supportive of publication with a few minor comments. While the authors focus on reflexive thematic analysis, there have been recent studies using advanced machine learning methods, such as t-SNE method, which can be used efficiently for classification as well as detecting trends in biochemical systems, which should be noted: Environ. Sci. Technol. Lett. 2023, 10, 1017–1022 and Mar. Genom. 2020, 51, 100723. In particular, these prior studies showed that t-SNE can give classification of results that could help diagnose trends in biochemical systems. I am not asking the authors to carry out such t-SNE calculations, but these recent applications of t-SNE should also be noted. ============================== Please submit your revised manuscript by Sep 05 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.... We look forward to receiving your revised manuscript. Kind regards, Asokan Govindaraj Vaithinathan Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please include a complete copy of PLOS’ questionnaire on inclusivity in global research in your revised manuscript. Our policy for research in this area aims to improve transparency in the reporting of research performed outside of researchers’ own country or community. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. The questionnaire can also be requested at the journal’s discretion for any other submissions, even if these conditions are not met. Please find more information on the policy and a link to download a blank copy of the questionnaire here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. Please upload a completed version of your questionnaire as Supporting Information when you resubmit your manuscript. 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. We note that you have indicated that there are restrictions to data sharing for this study. For studies involving human research participant data or other sensitive data, we encourage authors to share de-identified or anonymized data. However, when data cannot be publicly shared for ethical reasons, we allow authors to make their data sets available upon request. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. Please update your Data Availability statement in the submission form accordingly. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: Reviewer 1 The study uses a quantitative approach based on a thematic analysis of surveillance actors’ discourse to explore the challenges of operationalizing the One Health concept for the surveillance of zoonotic diseases, through the lens of collaboration across actors, at the sub-national level. Based on the findings of this analysis, the authors claim that they provide insights to strengthen intersectoral collaboration and improve public health outcomes. The manuscript is well written and easy to read up to the end of the methods section. Conversely, the format of the results section should be deeply revised. The thematic analysis allows you to identify relevant themes related to your research questions. But, when describing the results, and especially in a scientific article, you need to bring back everything together in a well-articulated text. No need to clearly state Theme 1, sub-theme 1, etc. They are not themes anymore, they are what you are willing to describe, eg factors. You can have one separate part for each key factors and then describe the sub-themes in these parts, mentioning if they are acting as barrier or driver. Then for parts B, C, and D, you should write a descriptive analysis of your factors and not provide the results in a table. You can refer to other articles in that field to see how to better structure your result section. I think this should allow you to group some of the sub-themes together among themes and across themes, among parts and across parts (see my comment in the Results sections about merging the 4 parts as motivation, expectations and benefits can also be considered as factors influencing collaboration). Some seem redundant. In addition, it is difficult to see how some verbatims are illustrating the text (for instance, verbatim lines 309-313). There are a lot of redundancies and inconsistencies in the discussion part. I suggest to restructure this part and make your message clearer. There are very interesting and innovative ideas but they are drowned out by repetition of things already said elsewhere in the discussion section or even in the results section. I have provided one example in the comment below, but it applies to other parts of the discussion. I am also surprised that you address the need to align expectations among stakeholders from the different sectors on one hand, but refer to collaboration outcomes only for public health on the other (lines 29-30). One Health is seeking shared benefits across the human, animal and ecosystem health. Supporting this anthropocentric definition of One Health – as done in this manuscript- is contributing to maintain expectation gaps across sectors. In general, you need to write more and avoid making lists with bullets or tables with a lot of text that is difficult to read You use “cross-sectoral”, “cross sector” and “inter-sectoral” to characterize collaboration in your manuscript. If you use them interchangeably, I would suggest to opt for one and keep it all along the manuscript. If they have different meaning, please specify. I would suggest to keep intersectoral collaboration in full, instead of using an acronym. Some typos need to be corrected. Abstract Line 28 : I would not use district as a synonym of operational – so better to choose between district and operational, and not keep the two side-by-side Line 35: when you say “governance and surveillance organization”, is organization applied to surveillance and governance or to surveillance only? In both cases, it sounds a bit strange to me. I wonder if “surveillance governance and organization” would not be more suitable. You announce 9 factors but I count only 8. Line 39: Please specify the outcomes of what. Collaboration? Line 45: we usually prefer to use collaboration without s Introduction Line 57: I do not see how limited public health infrastructure can favor spillover. Can you clarify? Line 59: 28 934 is not really an approximation and I am a bit skeptical about our capacity to count cases so precisely, especially in SSA where surveillance systems are weak … I would suggest “approximately 30 000”. Line 62: I think you could improve you definition of One Health. It is an integrated approach but it does not integrate healths – it recognizes that they are interconnected, which require “integrated” actions. Lines 63-65: I do not understand this sentence. Please clarify. Line 67: I would suggest to change “district (operational)” for “sub-national”. And then specify that you are working at the level of the district (and why) in the methodology part. Line 75 : I would suggest to delete “, or fails” that suggest that you anticipate that it is not working Line 79. I suggest to add “for zoonotic diseases” after systems. Methods Lines 101-102. Please describe briefly these criteria for the reader, so he.she can assess the potential impacts on the study results Line 119: the number of invitations sent is missing – did everyone accept to be part of the interview? if not, why? We are also missing the distribution of participants across the 16 districts to assess the level of representativity of each district Lines 137-138: ECoSur details organizational (at governance and operational level) and functional attributes (and not functional and governance attributes) Line 138. The “.” should be replaced by a “;”. Line 154 : I do not get how multiple readings ensure accuracy ; and accuracy of what? please explain I suggest to put together paragraph lines 80-82 with paragraph lines 91-96, and move the contents of lines 83-90 to the method part. It is usually advised that the coding is done by two people to improve accuracy. If you did not do it, you need to discuss this potential bias in the limits of the method Lines 171-178: the contents of these 2 paragraphs should be moved to Study design and Data collection Results Why did you address motivation, expectations, and perceived benefits separately from factors driving and hindering collaboration? To me they are also factors that influence collaboration. And you present them as such at the beginning of the discussion (lines 621-622). Please clarify and explain how everything is linked, or introduce them as specific themes in part A. and merge everything together Lines 183: why perceived? they were suggested by participants as factors? It is not what I understood in the methodology. They are perceptions of interviewees that you have identified, with your coding process, as being determinants to collaboration; but to me, they are not perceived factors per se (which suggests that interviewees identified themselves the factors) Line 186. I do not think that an expectation can be perceived Line 189: I do not get why assigning a unique identifier to participant will allow to link quotes to specific individuals. And I think the reader needs this information to assess the diversity of individuals you are quoting. It would be even better if you could give a code to the district where the interviewee is working to assess the representativeness of the districts Lines 196-197: you said that the factors are grouped into 2 categories (structural and individual) but then these categories are not used in the description of the factors. In addition, in the abstract you mention sociocultural, structural and governance factors, but you do not identify these groups in the Result section. You need to harmonize across the text. Then in the discussion part, you mention again the structural and individual factors but we do not know which ones fall into these 2 categories. Discussion In the abstract, you mention that levers for better collaborations are stronger governance, equitable partnerships, and realistic alignment of stakeholder expectations. However, in the discussion, we do not identify these 3 main levers. Lines 633-634. Please explain and not only make references to other articles. Lines 655-657. You refer to participants discourse but you had references to other studies. This is inconsistent. Lines 658-659. I do not see the link between the profit-driven dimension of collaboration and resource disparities among stakeholders. Please specify. Lines 678-683. I do not see how ideas in this paragraph articulates with each other. How will mutual respect and engagement contribute to raise awareness and access? It is also partly redundant with the contents of the paragraph before. Lines 684-690 seem redundant with what has been said before (sectoral visibility) Lines 754. You mention that focusing on Ghana prevents the generalization to other LMICs but in the abstract you state that you results are applicable to other LMICs. Please be clearer on what can be generalized and what cannot. In addition, you have worked on a limited number of districts in a single region. Can you even generalize your results to Ghana? Please discuss this point. Conclusions Lines 771. This is not the first study highlighting the role of informal networks, personal initiative, and structural Constraints in intersectoral collaboration. This has been described in some of the literature cited in this study; Line 779. Inconsistent with the limit you have mentioned above, about the generalization of your work (see my comment above). Line 780. Only public health outcomes? how about animal health outcomes? Economic outcomes? Social outcomes? … Reviewer 2 In this submission to PLOS One, the authors explore the factors influencing collaboration in zoonotic disease surveillance and response at the district (operational) level, providing insights to strengthen cross-sector collaboration and improve public health outcomes. The authors use reflexive thematic analysis to analyze interviews with 66 professionals from the human, animal, and wildlife health sectors, all directly involved in zoonotic disease surveillance and response. The authors find that their study provides insights into these realities, highlighting the need for stronger governance, equitable partnerships, and realistic alignment of stakeholder expectations. I consider this manuscript to be of interest to machine learning researchers in biological systems as well as readers of this journal. As such, I am generally supportive of publication with a few minor comments. While the authors focus on reflexive thematic analysis, there have been recent studies using advanced machine learning methods, such as t-SNE method, which can be used efficiently for classification as well as detecting trends in biochemical systems, which should be noted: Environ. Sci. Technol. Lett. 2023, 10, 1017–1022 and Mar. Genom. 2020, 51, 100723. In particular, these prior studies showed that t-SNE can give classification of results that could help diagnose trends in biochemical systems. I am not asking the authors to carry out such t-SNE calculations, but these recent applications of t-SNE should also be noted. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The study uses a quantitative approach based on a thematic analysis of surveillance actors’ discourse to explore the challenges of operationalizing the One Health concept for the surveillance of zoonotic diseases, through the lens of collaboration across actors, at the sub-national level. Based on the findings of this analysis, the authors claim that they provide insights to strengthen intersectoral collaboration and improve public health outcomes. The manuscript is well written and easy to read up to the end of the methods section. Conversely, the format of the results section should be deeply revised. The thematic analysis allows you to identify relevant themes related to your research questions. But, when describing the results, and especially in a scientific article, you need to bring back everything together in a well-articulated text. No need to clearly state Theme 1, sub-theme 1, etc. They are not themes anymore, they are what you are willing to describe, eg factors. You can have one separate part for each key factors and then describe the sub-themes in these parts, mentioning if they are acting as barrier or driver. Then for parts B, C, and D, you should write a descriptive analysis of your factors and not provide the results in a table. You can refer to other articles in that field to see how to better structure your result section. I think this should allow you to group some of the sub-themes together among themes and across themes, among parts and across parts (see my comment in the Results sections about merging the 4 parts as motivation, expectations and benefits can also be considered as factors influencing collaboration). Some seem redundant. In addition, it is difficult to see how some verbatims are illustrating the text (for instance, verbatim lines 309-313). There are a lot of redundancies and inconsistencies in the discussion part. I suggest to restructure this part and make your message clearer. There are very interesting and innovative ideas but they are drowned out by repetition of things already said elsewhere in the discussion section or even in the results section. I have provided one example in the comment below, but it applies to other parts of the discussion. I am also surprised that you address the need to align expectations among stakeholders from the different sectors on one hand, but refer to collaboration outcomes only for public health on the other (lines 29-30). One Health is seeking shared benefits across the human, animal and ecosystem health. Supporting this anthropocentric definition of One Health – as done in this manuscript- is contributing to maintain expectation gaps across sectors. In general, you need to write more and avoid making lists with bullets or tables with a lot of text that is difficult to read You use “cross-sectoral”, “cross sector” and “inter-sectoral” to characterize collaboration in your manuscript. If you use them interchangeably, I would suggest to opt for one and keep it all along the manuscript. If they have different meaning, please specify. I would suggest to keep intersectoral collaboration in full, instead of using an acronym. Some typos need to be corrected. Abstract Line 28 : I would not use district as a synonym of operational – so better to choose between district and operational, and not keep the two side-by-side Line 35: when you say “governance and surveillance organization”, is organization applied to surveillance and governance or to surveillance only? In both cases, it sounds a bit strange to me. I wonder if “surveillance governance and organization” would not be more suitable. You announce 9 factors but I count only 8. Line 39: Please specify the outcomes of what. Collaboration? Line 45: we usually prefer to use collaboration without s Introduction Line 57: I do not see how limited public health infrastructure can favor spillover. Can you clarify? Line 59: 28 934 is not really an approximation and I am a bit skeptical about our capacity to count cases so precisely, especially in SSA where surveillance systems are weak … I would suggest “approximately 30 000”. Line 62: I think you could improve you definition of One Health. It is an integrated approach but it does not integrate healths – it recognizes that they are interconnected, which require “integrated” actions. Lines 63-65: I do not understand this sentence. Please clarify. Line 67: I would suggest to change “district (operational)” for “sub-national”. And then specify that you are working at the level of the district (and why) in the methodology part. Line 75 : I would suggest to delete “, or fails” that suggest that you anticipate that it is not working Line 79. I suggest to add “for zoonotic diseases” after systems. Methods Lines 101-102. Please describe briefly these criteria for the reader, so he.she can assess the potential impacts on the study results Line 119: the number of invitations sent is missing – did everyone accept to be part of the interview? if not, why? We are also missing the distribution of participants across the 16 districts to assess the level of representativity of each district Lines 137-138: ECoSur details organizational (at governance and operational level) and functional attributes (and not functional and governance attributes) Line 138. The “.” should be replaced by a “;”. Line 154 : I do not get how multiple readings ensure accuracy ; and accuracy of what? please explain I suggest to put together paragraph lines 80-82 with paragraph lines 91-96, and move the contents of lines 83-90 to the method part. It is usually advised that the coding is done by two people to improve accuracy. If you did not do it, you need to discuss this potential bias in the limits of the method Lines 171-178: the contents of these 2 paragraphs should be moved to Study design and Data collection Results Why did you address motivation, expectations, and perceived benefits separately from factors driving and hindering collaboration? To me they are also factors that influence collaboration. And you present them as such at the beginning of the discussion (lines 621-622). Please clarify and explain how everything is linked, or introduce them as specific themes in part A. and merge everything together Lines 183: why perceived? they were suggested by participants as factors? It is not what I understood in the methodology. They are perceptions of interviewees that you have identified, with your coding process, as being determinants to collaboration; but to me, they are not perceived factors per se (which suggests that interviewees identified themselves the factors) Line 186. I do not think that an expectation can be perceived Line 189: I do not get why assigning a unique identifier to participant will allow to link quotes to specific individuals. And I think the reader needs this information to assess the diversity of individuals you are quoting. It would be even better if you could give a code to the district where the interviewee is working to assess the representativeness of the districts Lines 196-197: you said that the factors are grouped into 2 categories (structural and individual) but then these categories are not used in the description of the factors. In addition, in the abstract you mention sociocultural, structural and governance factors, but you do not identify these groups in the Result section. You need to harmonize across the text. Then in the discussion part, you mention again the structural and individual factors but we do not know which ones fall into these 2 categories. Discussion In the abstract, you mention that levers for better collaborations are stronger governance, equitable partnerships, and realistic alignment of stakeholder expectations. However, in the discussion, we do not identify these 3 main levers. Lines 633-634. Please explain and not only make references to other articles. Lines 655-657. You refer to participants discourse but you had references to other studies. This is inconsistent. Lines 658-659. I do not see the link between the profit-driven dimension of collaboration and resource disparities among stakeholders. Please specify. Lines 678-683. I do not see how ideas in this paragraph articulates with each other. How will mutual respect and engagement contribute to raise awareness and access? It is also partly redundant with the contents of the paragraph before. Lines 684-690 seem redundant with what has been said before (sectoral visibility) Lines 754. You mention that focusing on Ghana prevents the generalization to other LMICs but in the abstract you state that you results are applicable to other LMICs. Please be clearer on what can be generalized and what cannot. In addition, you have worked on a limited number of districts in a single region. Can you even generalize your results to Ghana? Please discuss this point. Conclusions Lines 771. This is not the first study highlighting the role of informal networks, personal initiative, and structural Constraints in intersectoral collaboration. This has been described in some of the literature cited in this study; Line 779. Inconsistent with the limit you have mentioned above, about the generalization of your work (see my comment above). Line 780. Only public health outcomes? how about animal health outcomes? Economic outcomes? Social outcomes? …. Reviewer #2: In this submission to PLOS One, the authors explore the factors influencing collaboration in zoonotic disease surveillance and response at the district (operational) level, providing insights to strengthen cross-sector collaboration and improve public health outcomes. The authors use reflexive thematic analysis to analyze interviews with 66 professionals from the human, animal, and wildlife health sectors, all directly involved in zoonotic disease surveillance and response. The authors find that their study provides insights into these realities, highlighting the need for stronger governance, equitable partnerships, and realistic alignment of stakeholder expectations. I consider this manuscript to be of interest to machine learning researchers in biological systems as well as readers of this journal. As such, I am generally supportive of publication with a few minor comments. While the authors focus on reflexive thematic analysis, there have been recent studies using advanced machine learning methods, such as t-SNE method, which can be used efficiently for classification as well as detecting trends in biochemical systems, which should be noted: Environ. Sci. Technol. Lett. 2023, 10, 1017–1022 and Mar. Genom. 2020, 51, 100723. In particular, these prior studies showed that t-SNE can give classification of results that could help diagnose trends in biochemical systems. I am not asking the authors to carry out such t-SNE calculations, but these recent applications of t-SNE should also be noted. ********** what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..--> Reviewer #1: Yes: Marion BordierMarion BordierMarion BordierMarion Bordier Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.. Please note that Supporting Information files do not need this step.. Please note that Supporting Information files do not need this step.. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Dsani, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 05 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.... We look forward to receiving your revised manuscript. Kind regards, Aravindh Babu Ramasamy Parthiban, B.V.Sc, M.V.Sc, Ph.D. Academic Editor PLOS ONE Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: Dear author, The comments from both the reviewers requires major revision to the manuscript. Please provide a point wise response to the comments Thanks and regards [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Partly Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: No Reviewer #2: Yes ********** Reviewer #1: Thank you for your detailed explanations. I still have a few comments, which I outline below. In the text below, I have kept my previous comment and your answers to them, when I was not fully satisfied, and explained why. I have also enclosed the word file which is may be easire for you to go through Abstract 2. Comment - Line 35: when you say “governance and surveillance organization”, is organization applied to surveillance and governance or to surveillance only? In both cases, it sounds a bit strange to me. I wonder if “surveillance governance and organization” would not be more suitable. Response – Thank you for this insightful observation. We agree with your suggestion and have revised the phrasing to ‘surveillance governance and organization systems’ in the manuscript and subsequent figures. (Line 35) Sorry, but it is still not clear to me. I suggested “the governance and organization of surveillance”. What do you mean by organization systems? system of what? In addition, you announce factors influencing disease surveillance and response, but mention only surveillance here. 5. Comment - Line 45: we usually prefer to use collaboration without ‘s’ Response – Thank you, the ‘s’ has been removed. (Line 44) But, it still remains in other parts of the manuscript Introduction 6. Comment - Line 57: I do not see how limited public health infrastructure can favor spillover. Can you clarify? Response - Thank you for this important clarification. You are correct that limited public health infrastructure does not directly favor spillover events. We have revised the sentence to clarify that while frequent human-animal interactions and weak surveillance systems create conditions for spillover, limited public health infrastructure facilitates the spread and impedes effective response. (Line 56-57) Still not clear to me. How weak surveillance systems creates conditions for spillover? The limited public health infrastructure facilitates the spread of what? I would move the weakness of surveillance to an additional factor that facilitate that impeded effective response. Lines 75-77 soften the statement of lines 69-71 and should be put side-by-side. Not sure that lines 71-74 are bringing relevant information in the context of this study. Lines 77-78. Why is it specifically crucial to understand collaboration dynamics when there is a high zoonotic disease burden and under-resourced health systems? The causal link is not obvious to me Lines 84-90 sound more like a conclusion than an introduction to the study that will be presented after. Should be rephrased. Methods Line 100: what do you mean by “which accounts for the higher participant numbers in one district” ? Line 103: what do you mean by component? Before, you are talking about objectives Lines 139-140. They agreed, but were they ultimately interviewed? 15. Comment - We are also missing the distribution of participants across the 16 districts to assess the level of representativity of each district. Response - Thank you for this suggestion. We understand the importance of demonstrating representativeness. However, providing district-level distribution data would significantly compromise participant confidentiality in our study context. The animal health sector has very small numbers of practitioners at the district level - in many cases only 1-2 per district - and since we interviewed complete teams in most districts, a table showing participant counts would essentially create a map that readers familiar with the animal health sector could use to identify specific districts. For example, if a table showed "District X has 4 animal health participants," colleagues in the sector would immediately know which district this refers to, as very few districts have 4 animal health officers. Combined with contextual details in quotes, this would compromise the anonymity we promised participants. We provide narrative information confirming that participants were recruited from across all 16 districts, with variation in numbers reflecting differences in sector sizes, purposive sampling of key ZDSR stakeholders, and one district's involvement in another study component (Lines 157-164). We believe this approach balances the need to demonstrate broad geographic representation with our ethical obligation to protect participant confidentiality in a small, highly interconnected professional community. Sorry, but it is not clear to me how you made your sampling. On one hand you are talking about purposive and convenience sampling, and then you say that you interviewed complete teams in most districts. In addition, you talk about 19 districts first, and then you say that participants were distributed across all 16 districts Be more precise about the sampling strategy used at each stage (selection of district, selection of participants). Lines 156-157 should be placed at the end of the previous paragraph Lines 158-160: I do not understand the causal link in this sentence I am not sure we need lines 160-164 Line 200: I would add discourse after participants. What do you think? Lines 222-223 – why do you have selected no verbatims for one district? Results I find the text difficult to read because all of the quotes that interrupt the text. May be, you can embed them in the text. Example: Personal rapport between actors was one of the strongest enablers of collaboration. Friendly relationships fostered trust, encouraged communication, and facilitated informal information exchange. As one animal health informant explained: “It’s because we have the rapport...” (AH) I would also suggest not to put one verbatim after each statement, but to articulate some statements together and choose the best illustrative verbatim (and the easier one to understand for people not familiar with the context, because a lot of verbatims are difficult to understand) It would be helpful to define what an assembly coordinator is as they are mentioned in a lot of verbatims Line 237-238. What is the difference between quotes integrated in the text and the ones provided in the supplementary file 1? line 246: you need to better explain this quote. What is “it” referring to? Lines 301-303 – It is not clear to me what you want to stress out. The professional recognition of who by whom create motivation of who? Lines 304: Self-protection is illustrated later lines 312-314. So why mentioning it here? Lines 310. What is NADMO? If we do not now, we do not see the collaboration here Lines 341-345. I do not see how this verbatim illustrate alignment between priorities of actors. The AH actor is talking about views, not priorities. This is more in line with the fact they are both new? Cf lines 251-256 Lines 556-557. Lack of exposure to what? We need to better see the link with the theme “knowledge and training” 22. Comment - Why did you address motivation, expectations, and perceived benefits separately from factors driving and hindering collaboration? To me they are also factors that influence collaboration. And you present them as such at the beginning of the discussion (lines 621-622). Please clarify and explain how everything is linked, or introduce them as specific themes in part A. and merge everything together Response - Thank you for this valuable comment. We agree that motivations, expectations, and perceived benefits all influence collaboration and should be integrated rather than treated separately. We have thus revised the Results section to reflect this (Lines 226 - 683). Specifically, we have: ��Reorganized our results into 'Factors Influencing Intersectoral Collaboration in ZDSR' with two categories: Individual factors (relationships, personal initiative, motivations, perceptions of superiority, shared goals), and Structural factors (governance, visibility, workforce availability, knowledge, and resource constraints). Positive collaborative outcomes fall within both individual and structural factors. ��Integrated ‘motivations’ into the ‘individual factors’, emphasizing that they represent participants' underlying incentives for engaging in collaboration. ��Renamed ‘perceived benefits’ to ‘Positive collaborative outcomes’ and placed it as a factor that falls under both individual and structural factors. ��Separated ‘general expectations for future collaboration’ as stakeholder aspirations to clearly distinguish aspirational views from demonstrated influences on current collaboration. This restructuring creates a more cohesive framework linking motivations, experiences, and expectations as interconnected influences on collaboration. Ok, but you should mention in the introduction of the Results’ section the positive outcomes, the facts that they may be Individual of Structural factors and that’s why you address them separately Discussion There is still work to be done on the discussion. It could be more concise and better articulated. In addition, there are often very broad and somewhat vague recommendations, and we would like the authors to go a little further in explaining how these recommendations could be implemented in the context of Ghana and in light of their work. Line 723. What do you mean by inequities? Is that linked to power imbalances that you are mentioning below? If yes, the link between the two paragraphs should be clearer. I can see that you are also mentioning inequities line 732 Lines 724. I would take the opportunity of this section to discuss the fact that participants perceived that medics trained in Public health are more collaborative than the ones who are not Line 726. I understand your point but, to me, power imbalance is real as the human health sector is usually more well-resourced than the animal health sector. Line 737-740. But what do you propose for this to happen? We have seen that almost all African countries have now One Health Platforms but they are barely non functional and inequities as well as power imbalances persist. So how can we make OH institutionalisation working? Some studies show that too rigid institutional mechanisms also hamper collaboration because people see a risk to loose their autonomy and to be “forced” to do things they do not want to do (such as sharing data). In addition, I am not sure that institutionalization is synonymous of equity. We have seen that institutionalization may also reinforce inequity. For instance, all international regulations which are mainly focusing on priorities of the “North” shape how funding is allocated to countries and to specific national counterparts. However those countries might have other priorities than the ones the international standards are focusing on and the funding mechanisms may create competition between national actors to accede fundings Line 750. Poor enforcement of what? Line 754-756. Ok, but how to achieve this? In the previous paragraph, you are calling for more institutionalisation, but now you say that it is not enough for collaboration to be effective. You need to discuss these two points together and propose concrete solutions to that or at least way of improvement. Line 769. I do not understand what this paragraph is adding to what is described previously. You mention physical proximity but then you are mainly refering to visibility, and are redundant with the previous paragraph. These two paragraphs should be merged and ideas better articulated Lines 825-827. To my knowledge, it has been already addressed in the literature. See for instance: https://doi.org/10.1186/s12889-022-13878-3. Lines 829-833. I don't see how you are proposing a roadmap; at best, you are proposing avenues for reflection and points to consider. Lines 824- 833. I do not see how this paragraph relates to Bridging Expectation–Reality Gaps. It looks more like a summary of what you have highlighted before. It could be merged with your paragraph about the potential generalisation of your results to Ghana and LMICS and rename your sections Limits by Limits and perspectives Line 849. Should be Third? Lines 850-856. This is not a limitation because it was not the objective of your work to be able to generalize to Ghana and to all LMICS. Lines 860-863. This sections could be merge with the first one to be more concise Line 880. As stated before, I fail to see how this work has bridged the gap between policy and practice, and what you really mean with this statement. Which gap you are talking about? What is policy for you?. You have explored facilitators and barriers to collaboration at operational level, and address the importance of institutionalisation (closely linked to policy), but I don’t really see where you have improved the alignment between policy decisions and field practice. Reviewer #2: The authors did not address my previous review comments. I have re-pasted them below. Until the authors address them, I recommend re-review of this manuscript: I consider this manuscript to be of interest to machine learning researchers in biological systems as well as readers of this journal. As such, I am generally supportive of publication with a few minor comments. While the authors focus on reflexive thematic analysis, there have been recent studies using advanced machine learning methods, such as t-SNE method, which can be used efficiently for classification as well as detecting trends in biochemical systems, which should be noted: Environ. Sci. Technol. Lett. 2023, 10, 1017–1022 and Mar. Genom. 2020, 51, 100723. In particular, these prior studies showed that t-SNE can give classification of results that could help diagnose trends in biochemical systems. I am not asking the authors to carry out such t-SNE calculations, but these recent applications of t-SNE should also be noted. ********** what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..--> Reviewer #1: Yes: Marion BordierMarion BordierMarion BordierMarion Bordier Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.
|
| Revision 2 |
|
Dear Dr. Dsani, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 09 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.... As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff the individual author can complete the verification step; PLOS staff the individual author can complete the verification step; PLOS staff the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. verify ORCID iDs on behalf of authors. verify ORCID iDs on behalf of authors. verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Julian Ruiz-Saenz, PhD Academic Editor PLOS One Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: We note that reviewer 2 has requested citation of their previous work. It is appropriate for reviewers to request that authors discuss closely related literature and cite additional sources, and in some cases the reviewer’s work may be relevant to the submitted manuscript. However, requests to cite the reviewer's work should be on topic and always be noted as optional. Here it appears that the work is outside of the scope of the current study. PLOS ONE considers qualitative and mixed-methods studies for publication. We recommend that authors use the COREQ checklist, or other relevant checklists listed by the Equator Network, such as the SRQR, to ensure complete reporting (http://journals.plos.org/plosone/s/submission-guidelines#loc-qualitative-research). In general, we would expect qualitative studies to include the following: 1) defined objectives or research questions; 2) description of the sampling strategy, including rationale for the recruitment method, participant inclusion/exclusion criteria and the number of participants recruited; 3) detailed reporting of the data collection procedures; 4) data analysis procedures described in sufficient detail to enable replication; 5) a discussion of potential sources of bias; and 6) a discussion of limitations. Authors conducting research in other countries or with Indigenous populations are required to complete a copy of PLOS’ questionnaire on inclusivity in global research. The policy applies to researchers who have travelled to a different country to conduct research, research with Indigenous populations or their lands, and research on cultural artefacts. You can find more information on this policy here: https://journals.plos.org/plosone/s/best-practices-in-research-reporting. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously?-->?> Reviewer #1: N/A Reviewer #2: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.--> Reviewer #1: Yes Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: (No Response) ********** Reviewer #1: Thank you for responding in such detail to all my comments. Good luck with the finalization of this submission. Reviewer #2: The authors did not address my previous review comments. I have re-pasted them below. Until the authors address them, I recommend re-review of this manuscript: I consider this manuscript to be of interest to machine learning researchers in biological systems as well as readers of this journal. As such, I am generally supportive of publication with a few minor comments. While the authors focus on reflexive thematic analysis, there have been recent studies using advanced machine learning methods, such as t-SNE method, which can be used efficiently for classification as well as detecting trends in biochemical systems, which should be noted: Environ. Sci. Technol. Lett. 2023, 10, 1017–1022 and Mar. Genom. 2020, 51, 100723. In particular, these prior studies showed that t-SNE can give classification of results that could help diagnose trends in biochemical systems. I am not asking the authors to carry out such t-SNE calculations, but these recent applications of t-SNE should also be noted. ********** what does this mean?). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files.). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our For information about this choice, including consent withdrawal, please see our Privacy Policy..--> Reviewer #1: Yes: Marion BordierMarion BordierMarion BordierMarion Bordier Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 3 |
|
Beyond silos: Drivers and barriers to intersectoral collaboration in zoonotic disease surveillance and response in the Greater Accra Metropolitan Area, Ghana PONE-D-25-16092R3 Dear Dr. Dsani, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support.... If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Julian Ruiz-Saenz, PhD. Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-25-16092R3 PLOS One Dear Dr. Dsani, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Julian Ruiz-Saenz Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .